Greatbatch-AVX Trial's Willfulness Stage Ends In Hung Jury

Law360, Wilmington (August 11, 2017, 9:50 PM EDT) -- A Delaware federal jury deadlocked Friday on a Greatbatch Ltd. claim that AVX Corp. acted willfully when it infringed a medical implant component patent, ending a week of split trial outcomes for the two industry competitors and longtime intellectual property antagonists.

A Greatbatch attorney told the jury before it began deliberation that AVX made changes to the infringing implant component in late 2013 and early 2014 without informing its customer, Boston Scientific, because it knew its product stepped on U.S. Patent Number 6,888,715. (AP) The same...
To view the full article, register now.